Related Experiment Video
Updated: Jun 28, 2026
10:08
Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
Published on: August 28, 2012
Intracellular apolipoprotein E affects Amyloid Precursor Protein processing and amyloid Abeta production in COS-1
S Hass1, A Weidemann, G Utermann
1Institute for Medical Biology and Human Genetics, University of Innsbruck, Austria.
Molecular Genetics and Genomics : MGG
|August 29, 2001
Summary
Apolipoprotein E (apoE) epsilon4 allele is linked to earlier onset of late-onset Alzheimer's disease (LOAD). This study reveals apoE interacts with Amyloid Precursor Protein (APP), affecting its processing and increasing amyloid-beta (Abeta) production, particularly with the epsilon4 variant.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- The apolipoprotein E (apoE) gene is a key genetic risk factor for late-onset Alzheimer's disease (LOAD).
- The epsilon4 allele of apoE is associated with an earlier age of onset for LOAD compared to the epsilon3 allele.
- The precise molecular mechanisms linking apoE to Alzheimer's pathogenesis remain incompletely understood.
Purpose of the Study:
- To investigate the intracellular interaction between apoE and Amyloid Precursor Protein (APP).
- To determine how this interaction influences APP processing and amyloid-beta (Abeta) production.
- To elucidate allele-specific effects of apoE on APP metabolism.
Main Methods:
- Utilized apoE fusion proteins with ER retention (KDEL) or TGN signal sequences.
- Performed co-expression and pulse-chase experiments to track protein processing and secretion.
- Analyzed Abeta production in response to different apoE variants and cellular targeting.
Main Results:
- Demonstrated an intracellular functional interaction between apoE and APP.
- Showed that this interaction modulates APP maturation and secretion kinetics.
- Revealed an epsilon4 allele-specific increase in Abeta production, with apoE3 increasing Abeta when targeted to the ER.
Conclusions:
- The apoE:APP interaction occurs intracellularly and impacts APP processing.
- ApoE influences Abeta production, with specific effects related to the apoE allele and cellular localization.
- These findings suggest a mechanism by which apoE modulates APP processing and Abeta generation in relevant cell types like astrocytes and microglia.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:29Protein Folding Quality Check in the RER
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
01:32Export of Misfolded Proteins out of the ER
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...